News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,066 Results
Type
Article (3835)
Company Profile (7)
Press Release (53224)
Section
Business (11457)
Career Advice (62)
Deals (2177)
Drug Delivery (6)
Drug Development (10782)
Employer Resources (9)
FDA (2341)
Job Trends (1299)
News (26935)
Policy (2476)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (229)
Accelerated approval (4)
Adcomms (3)
Allergies (7)
Alliances (3000)
ALS (8)
Alzheimer's disease (64)
Antibody-drug conjugate (ADC) (38)
Approvals (2410)
Artificial intelligence (26)
Autoimmune disease (18)
Automation (1)
Bankruptcy (9)
Best Places to Work (1258)
BIOSECURE Act (3)
Biosimilars (44)
Biotechnology (4)
Bladder cancer (9)
Brain cancer (9)
Breast cancer (61)
Cancer (492)
Cardiovascular disease (49)
Career advice (58)
Career pathing (1)
CAR-T (46)
CDC (1)
Cell therapy (107)
Cervical cancer (1)
Clinical research (9842)
Collaboration (105)
Compensation (41)
Complete response letters (4)
COVID-19 (96)
CRISPR (7)
C-suite (39)
Cystic fibrosis (5)
Data (954)
Decentralized trials (1)
Depression (6)
Diabetes (44)
Diagnostics (363)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (23)
Drug pricing (15)
Drug shortages (1)
Duchenne muscular dystrophy (36)
Earnings (5867)
Editorial (5)
Employer branding (3)
Employer resources (10)
Events (8095)
Executive appointments (28)
FDA (2759)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (1)
Funding (74)
Gene editing (14)
Generative AI (2)
Gene therapy (46)
GLP-1 (117)
Government (274)
Guidances (46)
Healthcare (1893)
HIV (10)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (20)
Immuno-oncology (2)
Indications (11)
Infectious disease (117)
Inflammatory bowel disease (31)
Influenza (9)
Intellectual property (20)
Interviews (14)
IPO (1155)
Job creations (118)
Job search strategy (43)
JPM (4)
Kidney cancer (1)
Labor market (2)
Layoffs (13)
Leadership (2)
Legal (327)
Liver cancer (9)
Longevity (2)
Lung cancer (27)
Lymphoma (83)
Machine learning (2)
Management (3)
Manufacturing (48)
MASH (12)
Medical device (1474)
Medtech (1482)
Mergers & acquisitions (1077)
Metabolic disorders (153)
Multiple sclerosis (10)
Neurodegenerative disease (12)
Neuropsychiatric disorders (5)
Neuroscience (106)
NextGen: Class of 2026 (447)
Non-profit (296)
Now hiring (2)
Obesity (87)
Opinion (34)
Ovarian cancer (9)
Pain (27)
Pancreatic cancer (5)
Parkinson's disease (6)
Partnered (1)
Patents (24)
Patient recruitment (48)
Peanut (1)
People (2438)
Pharmaceutical (1)
Pharmacy benefit managers (4)
Phase 1 (2482)
Phase 2 (4115)
Phase 3 (3821)
Pipeline (592)
Policy (16)
Postmarket research (460)
Preclinical (955)
Prostate cancer (33)
Psychedelics (1)
Radiopharmaceuticals (34)
Rare diseases (120)
Real estate (195)
Recruiting (1)
Regulatory (2400)
Reports (7)
Research institute (252)
Resumes & cover letters (5)
Rett syndrome (2)
RSV (9)
Schizophrenia (2)
Series A (11)
Series B (6)
Sickle cell disease (25)
Special edition (1)
Spinal muscular atrophy (7)
Sponsored (5)
Startups (195)
Stomach cancer (1)
Supply chain (7)
Tariffs (7)
The Weekly (2)
Vaccines (81)
Venture capital (5)
Weight loss (45)
Women's health (9)
Worklife (2)
Date
Last 7 days (38)
Last 30 days (169)
Last 365 days (2621)
2026 (220)
2025 (2647)
2024 (3080)
2023 (3433)
2022 (4619)
2021 (5084)
2020 (4544)
2019 (3790)
2018 (3044)
2017 (3142)
2016 (2850)
2015 (3311)
2014 (2302)
2013 (1735)
2012 (1848)
2011 (2031)
2010 (1706)
Location
Africa (66)
Alabama (12)
Arizona (15)
Arkansas (2)
Asia (3817)
Australia (528)
California (943)
Canada (157)
China (108)
Colorado (36)
Connecticut (37)
Delaware (39)
Europe (7919)
Florida (170)
Georgia (25)
Idaho (5)
Illinois (106)
India (11)
Indiana (56)
Iowa (4)
Japan (62)
Kansas (7)
Kentucky (1)
Louisiana (2)
Maine (21)
Maryland (109)
Massachusetts (659)
Michigan (16)
Minnesota (39)
Missouri (4)
Montana (2)
Nevada (7)
New Jersey (327)
New Mexico (3)
New York (335)
North Carolina (85)
Northern California (499)
Ohio (20)
Oklahoma (1)
Oregon (8)
Pennsylvania (167)
Puerto Rico (1)
Rhode Island (1)
South America (101)
South Carolina (1)
Southern California (347)
Tennessee (8)
Texas (109)
United States (3389)
Utah (17)
Virginia (35)
Washington D.C. (5)
Washington State (54)
Wisconsin (1)
57,066 Results for "bone index".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 29, 2026
·
2 min read
Press Releases
Abivax to be Added to Nasdaq Biotechnology Index
December 19, 2025
·
1 min read
Press Releases
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 24, 2025
·
4 min read
Press Releases
Lifecore Biomedical to be Added to Nasdaq Biotech Index
December 18, 2025
·
1 min read
Press Releases
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 17, 2025
·
1 min read
Press Releases
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
·
1 min read
Press Releases
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 23, 2025
·
3 min read
Press Releases
Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
January 14, 2026
·
6 min read
Press Releases
Indivior Announces Inclusion in the S&P SmallCap 600® Index
December 23, 2025
·
1 min read
Press Releases
FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue
January 29, 2026
·
3 min read
1 of 5,707
Next
